News Headline Summary

Bristol-Myers (BMY) Hepatitis C combo therapy shows promise in study

Reaction details (20:32)

- BMY pops to the upside in reaction to this headline, moving higher by 0.3%; trades USD 32.03 last.

12 Nov 2012 - 20:30 - Equities - Source: Newswires

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: